close

Fenwick & West Represents Becton in Acquisition of Cytopeia

May 28, 2008

Fenwick & West LLP represented Becton, Dickinson and Company (NYSE: BDX) in its recently announced acquisition of Seattle, WA-based Cytopeia Inc., a developer of flow cytometry and cell sorting instruments. Financial terms of the acquisition were not disclosed. The acquisition was initially announced on May 13, 2008 and closed the same day.

More information about the transaction can be obtained from the BD Web site.

The Fenwick & West transaction team included corporate attorneys Stephen Graham, Michael Piraino, Elizabeth Barclay-Bekiroglu, Andrew Albertson and Kee Bong Kim; executive compensation and employee benefits attorneys Scott Spector, Gerald Audant and John Ludlum; technology transactions attorney Roger Tolbert; and corporate paralegal Ellen Welichko.


About Fenwick & West

Fenwick & West provides comprehensive legal services to technology and life sciences clients of national and international prominence. The firm is ranked by MergerMarket as one of the top 5 technology M&A practices in the U.S. and by Mergerstat as one of the top 15 U.S. law firms for life sciences M&A.​